Original Article

Risk Factors for Predicting Osteoporosis in Patients Who Receive Thyrotropin Suppressive Levothyroxine Treatment for Differentiated Thyroid Carcinoma
  • Çiğdem Soydal
  • Elgin Özkan
  • Demet Nak
  • Atilla Halil Elhan
  • Nuriye Özlem Küçük
  • Metin Kemal Kır
Mol Imaging Radionucl Ther 2019; 28: 69-75 DOI: 10.4274/mirt.galenos.2019.89410
Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma
  • Aylin Oral
  • Bülent Yazıcı
  • Cenk Eraslan
  • Zeynep Burak
Mol Imaging Radionucl Ther 2018; 27: 99-106 DOI: 10.4274/mirt.37450 PMID:30317832

Review

Radioactive Iodine Therapy of Differentiated Thyroid Carcinoma: Redesigning the Paradigm
  • Stanley J. Goldsmith
Mol Imaging Radionucl Ther 2017; 26: 74-79 DOI: 10.4274/2017.26.suppl.08 PMID:28117291

Original Research

The Evaluation of Microcarcinoma in Differentiated Thyroid Cancers According to Old and New TNM Classification
  • Zekiye Hasbek
  • Bülent Turgut
  • Taner Erselcan
  • Ayhan Koyuncu
  • Mehmet Fatih Börksüz
  • Nergiz Hacer Turgut
  • Fadime Yumuk
Mol Imaging Radionucl Ther 2011; 20: 94-99 DOI: 10.4274/MIRT.13 PMID:23486990

Case Report

Aggressive Disease Course of Papillary Thyroid Carcinoma with Focal Undifferentiated Component: A Case Report
  • Saima Riaz
  • Humayun Bashir
  • Aamna Hassan
  • Sajid Mushtaq
  • Arif Jamshed
  • Ahmad Murtaza
Mol Imaging Radionucl Ther 2016; 25: 134-139 DOI: 10.4274/mirt.38358 PMID:27751976

About Journal

Forms

Useful Links

Applications